Frequently asked questions about single dose HPV vaccination

High–quality evidence assessing single–dose HPV vaccination suggests that implementing a single–dose schedule is scientifically sound, and provides the greatest public health benefit.

A single–dose HPV vaccination schedule has the potential to reach more girls and avert a greater number of cervical cancer cases than reaching fewer girls with a two–dose regimen.

This brief provides a list of frequently asked questions and answers about the evidence around single–dose HPV vaccination, and the current policy landscape.

Publication date: April 2024

Available materials

  1. English

    1. Frequently asked questions about single dose HPV vaccination 293.7 KB PDF

  2. French

    1. Foire Aux Questions 297.9 KB PDF

  3. Spanish

    1. Preguntas Frecuentes 339 KB PDF